SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
VWF 的表面和配体受体相互作用
基本信息
- 批准号:2750625
- 负责人:
- 金额:$ 19.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-08-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:atomic force microscopy coagulation factor VIII conformation fluorescence microscopy hemodynamics human tissue image processing intermolecular interaction ligands mechanical stress monoclonal antibody protein structure function receptor binding receptor expression structural biology von Willebrand factor
项目摘要
von Willebrand Factor (vWF) plays central role in regulation of hemostasis
and thrombosis by participating in blood coagulation and facilitating
adhesion and aggregation of platelets. The dual roles are integral to the
maintenance of hemostasis after vasculature injury or in the presence of
an implanted cardiovascular device. While the general sequence of
functional events involving vWF is known, the corresponding structural
changes in vWF have not been determined on a molecular scale under aqueous
conditions. The proposed studies focus on elucidation of the three (3D)
dimensional (tertiary) structure of vWF under physiologic and
pathophysiologic shear conditions using the novel technique of atomic
force microscopY (AFM). The central hypothesis to be examined is that
there is a close relationship between the conformational state of vWF and
expression of the protein's functional binding domains. The specific aims
of this project include: (1) determination of the 3D conformation of vWF
multimers on different adhesive substrata (collagens, heparin, artificial
surfaces) under hemodynamic conditions of increasing shear stress; (2)
identification of the Factor VIII functional binding domain in the
tertiary structure of surface adsorbed vWF; (3) identification and mapping
on a sub-nanometer scale of exposed surface charge domains of vWF; and (4)
quantification of the intermolecular adhesive forces involved in specific
vWF ligand-receptor interactions including peptide segments of the Al
domain and RGDX ligand binding to platelet integral membrane receptors
GPIb and GPIIb-IIIa and to collagen or heparinized substrata. The unique
capabilities of AFM to measure both 3D structure and intermolecular forces
will be the central technique used in these studies. A range of in vitro
dynamic flow conditions extending from stasis to pathophysiologic shear
stresses will be quantified and controlled using a rotating disk system
and a laminar flow chamber. Conformational studies will be directly
correlated to the functional state of vWF using complimentary assays
including platelet adhesion determined by high resolution fluorescence
microscopy, and by FITC labeled and gold bead labeled monoclonal
antibodies to known vWF epitopes. These studies will contribute new
insights and understanding of vWF structure-function relations under a
range of shear conditions and in developing a comprehensive understanding
of thrombogenesis.
血管性血友病因子(vWF)在止血调节中起着重要作用
和血栓形成,通过参与血液凝固和促进
血小板的粘附和聚集。双重角色是不可或缺的,
血管损伤后或存在以下情况下维持止血
一种植入的心血管装置虽然一般序列
涉及vWF的功能性事件是已知的,相应的结构性
vWF的变化尚未在水环境下在分子尺度上确定。
条件拟议的研究重点是阐明这三个(3D)
在生理和生理条件下vWF的三维(三级)结构
病理生理剪切条件下使用的新技术的原子
力显微镜(AFM)。要检验的中心假设是,
vWF的构象状态与
蛋白质的功能结合结构域的表达。具体目标
本课题的主要研究内容包括:(1)vWF的三维构象测定
在不同的粘附基质(胶原、肝素、人工
表面)在血流动力学条件下增加剪切应力;(2)
在所述细胞中鉴定因子VIII功能性结合结构域,
表面吸附vWF的三级结构;(3)鉴定和作图
在亚纳米尺度上的vWF的暴露表面电荷域;和(4)
分子间粘附力的定量参与的具体
vWF配体-受体相互作用,包括Al的肽段
结构域和RGDX配体与血小板整合膜受体的结合
GPIb和GPIIb-IIIa以及胶原或肝素化基质。独特的
AFM测量3D结构和分子间力的能力
将是这些研究中使用的核心技术。一系列体外
从停滞到病理生理剪切的动态流动条件
将使用旋转盘系统来量化和控制应力
和层流室。构象研究将直接
与vWF的功能状态相关,
包括通过高分辨率荧光测定的血小板粘附
显微镜下,并通过FITC标记和金珠标记的单克隆抗体,
已知vWF表位的抗体。这些研究将有助于新的
vWF结构-功能关系的见解和理解,
剪切条件的范围,并在发展一个全面的了解
血栓形成
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER E MARCHANT其他文献
ROGER E MARCHANT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER E MARCHANT', 18)}}的其他基金
Cell-Selective Liposomal Drug Delivery In Restenosis
再狭窄中的细胞选择性脂质体药物递送
- 批准号:
6729145 - 财政年份:2002
- 资助金额:
$ 19.89万 - 项目类别:
Cell-Selective Liposomal Drug Delivery In Restenosis
再狭窄中的细胞选择性脂质体药物递送
- 批准号:
6623483 - 财政年份:2002
- 资助金额:
$ 19.89万 - 项目类别:
Cell-Selective Liposomal Drug Delivery In Restenosis
再狭窄中的细胞选择性脂质体药物递送
- 批准号:
6466235 - 财政年份:2002
- 资助金额:
$ 19.89万 - 项目类别:
Cell-Selective Liposomal Drug Delivery In Restenosis
再狭窄中的细胞选择性脂质体药物递送
- 批准号:
6872197 - 财政年份:2002
- 资助金额:
$ 19.89万 - 项目类别:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
VWF 的表面和配体受体相互作用
- 批准号:
2372966 - 财政年份:1997
- 资助金额:
$ 19.89万 - 项目类别:
相似海外基金
Elucidation of the origin of blood coagulation factor VIII-producing cells for the development of new hemophilia treatment
阐明凝血因子 VIII 产生细胞的起源,用于开发新的血友病治疗方法
- 批准号:
18K08370 - 财政年份:2018
- 资助金额:
$ 19.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The response of endothelial cells and the function of coagulation factor VIII under flow conditions
流动条件下内皮细胞的反应和凝血因子VIII的功能
- 批准号:
17K10126 - 财政年份:2017
- 资助金额:
$ 19.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel gene therapy by full-length coagulation factor VIII
全长凝血因子 VIII 的新型基因疗法
- 批准号:
26670264 - 财政年份:2014
- 资助金额:
$ 19.89万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Role of coagulation Factor VIII in Thrombosis in vivo
凝血因子 VIII 在体内血栓形成中的作用
- 批准号:
6998835 - 财政年份:2004
- 资助金额:
$ 19.89万 - 项目类别:
THE EVOLUTION OF BLOOD COAGULATION FACTOR VIII IN MAMMALS
哺乳动物凝血因子 VIII 的进化
- 批准号:
12670771 - 财政年份:2000
- 资助金额:
$ 19.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)